Company profile for Alfasigma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigm...
Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist. From the beginning Alfasigma has always pursued a twofold strategy: – internally, a strong focus on Research & Development and Manufacturing around some proprietary molecules, some of which represent more than 50% of the sales.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Bologna - Via Ragazzi del ‘99, 5
Telephone
Telephone
+39 0516489511
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/11/3148535/23024/en/Intercept-Announces-Voluntary-Withdrawal-of-OCALIVA-for-Primary-Biliary-Cholangitis-PBC-from-the-US-Market-US-Clinical-Trials-Involving-Obeticholic-Acid-Placed-on-Clinical-Hold.html

GLOBENEWSWIRE
11 Sep 2025

https://www.fiercepharma.com/pharma/alfasigma-touts-results-phase-3-trial-former-galapagos-jak-inhibitor-jyseleca

FIERCE PHARMA
30 Jul 2025

https://www.businesswire.com/news/home/20250728902063/en/Filgotinib-Shows-Positive-Topline-Results-Across-Full-Spectrum-of-Axial-Spondyloarthritis-in-OLINGUITO-Phase-3-Study

BUSINESSWIRE
28 Jul 2025

https://www.prnewswire.com/news-releases/forging-new-paths-alfasigma-group-and-fangzhou-inc-chart-a-course-for-internet-healthcare-302310791.html

PR NEWSWIRE
19 Nov 2024

https://endpts.com/fda-is-poised-to-pull-ocaliva-as-adcomm-documents-question-post-approval-study-results/

ENDPTS
12 Sep 2024

https://www.globenewswire.com/news-release/2024/09/06/2942227/23024/en/Findings-From-COBALT-Trial-Including-External-Control-Arm-Published-in-The-American-Journal-of-Gastroenterology.html

GLOBENEWSWIRE
06 Sep 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Alfasigma and get a quotation

Alfasigma is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Meprobamate bulk offered by Alfasigma

Find a price of Naproxen Sodium bulk offered by Alfasigma

Find a price of Tolbutamide bulk offered by Alfasigma

Find a price of Sulodexide bulk offered by Alfasigma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty